GB9914743D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB9914743D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1999-06-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9914743.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott GmbH and Co KG

Original Assignee

Knoll GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-24

Filing date

1999-06-24

Publication date

1999-08-25

1999-06-24 Application filed by Knoll GmbH filed Critical Knoll GmbH

1999-06-24 Priority to GBGB9914743.1A priority Critical patent/GB9914743D0/en

1999-08-25 Publication of GB9914743D0 publication Critical patent/GB9914743D0/en

2000-06-16 Priority to JP2001505896A priority patent/JP2003503343A/en

2000-06-16 Priority to MXPA01013421A priority patent/MXPA01013421A/en

2000-06-16 Priority to EP00947848A priority patent/EP1218008A2/en

2000-06-16 Priority to PCT/EP2000/005543 priority patent/WO2001000186A2/en

2000-06-16 Priority to CA002376886A priority patent/CA2376886A1/en

2000-06-16 Priority to AU61502/00A priority patent/AU6150200A/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Endocrinology (AREA)
Addiction (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

GBGB9914743.1A 1999-06-24 1999-06-24 Therapeutic agents Ceased GB9914743D0 (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GBGB9914743.1A GB9914743D0 (en)	1999-06-24	1999-06-24	Therapeutic agents
JP2001505896A JP2003503343A (en)	1999-06-24	2000-06-16	Therapeutic agent
MXPA01013421A MXPA01013421A (en)	1999-06-24	2000-06-16	Therapeutic agents.
EP00947848A EP1218008A2 (en)	1999-06-24	2000-06-16	New use of 1,2,4-triazolo[1,5-a]pyrimidines
PCT/EP2000/005543 WO2001000186A2 (en)	1999-06-24	2000-06-16	New use of 1,2,4-triazolo'1,5-a! pyrimidines
CA002376886A CA2376886A1 (en)	1999-06-24	2000-06-16	Therapeutic agents
AU61502/00A AU6150200A (en)	1999-06-24	2000-06-16	Therapeutic agents

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9914743.1A GB9914743D0 (en)	1999-06-24	1999-06-24	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB9914743D0 true GB9914743D0 (en)	1999-08-25

Family

ID=10855954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9914743.1A Ceased GB9914743D0 (en)	1999-06-24	1999-06-24	Therapeutic agents

Country Status (7)

Country	Link
EP (1)	EP1218008A2 (en)
JP (1)	JP2003503343A (en)
AU (1)	AU6150200A (en)
CA (1)	CA2376886A1 (en)
GB (1)	GB9914743D0 (en)
MX (1)	MXPA01013421A (en)
WO (1)	WO2001000186A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010056631A1 (en)	2008-11-12	2010-05-20	Schering Corporation	Inhibitors of fatty acid binding protein (fabp)
WO2011043994A1 (en)	2009-10-08	2011-04-14	Schering Corporation	Inhibitors of fatty acid binding protein (fabp)
KR101775682B1 (en)	2015-11-30	2017-09-06	주식회사 대웅	Methods for Preparing Botulinum Toxin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9321162D0 (en) *	1993-10-13	1993-12-01	Boots Co Plc	Therapeutic agents
GB9906126D0 (en) *	1999-03-18	1999-05-12	Knoll Ag	Pharmaceutical formulations
GB9906130D0 (en) *	1999-03-18	1999-05-12	Knoll Ag	Compounds for use in therapy
GB9906124D0 (en) *	1999-03-18	1999-05-12	Knoll Ag	Therapeutic agent

1999
- 1999-06-24 GB GBGB9914743.1A patent/GB9914743D0/en not_active Ceased
2000
- 2000-06-16 CA CA002376886A patent/CA2376886A1/en not_active Abandoned
- 2000-06-16 EP EP00947848A patent/EP1218008A2/en not_active Withdrawn
- 2000-06-16 WO PCT/EP2000/005543 patent/WO2001000186A2/en not_active Application Discontinuation
- 2000-06-16 MX MXPA01013421A patent/MXPA01013421A/en unknown
- 2000-06-16 AU AU61502/00A patent/AU6150200A/en not_active Abandoned
- 2000-06-16 JP JP2001505896A patent/JP2003503343A/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1218008A2 (en)	2002-07-03
MXPA01013421A (en)	2002-07-30
CA2376886A1 (en)	2001-01-04
WO2001000186A3 (en)	2002-05-10
WO2001000186A2 (en)	2001-01-04
JP2003503343A (en)	2003-01-28
AU6150200A (en)	2001-01-31

Publication	Publication Date	Title
GB9911863D0 (en)	1999-07-21	Therapeutic agents
GB9905010D0 (en)	1999-04-28	Therapeutic agents
HK1200316A1 (en)	2015-08-07	Therapeutic microfoams
IL150030A0 (en)	2002-12-01	Therapeutic agents
GB9904786D0 (en)	1999-04-28	Therapeutic agents
GB9929685D0 (en)	2000-02-09	Therapeutic agents
GB9929687D0 (en)	2000-02-09	Therapeutic agents
GB9911881D0 (en)	1999-07-21	Therapeutic agents
GB9921351D0 (en)	1999-11-10	Therapeutic agents
GB9813006D0 (en)	1998-08-12	Therapeutic agents
PL339848A1 (en)	2000-10-23	Therapeutic agent against hypephosphataemia
GB9801210D0 (en)	1998-03-18	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9903476D0 (en)	1999-04-07	Therapeutic agents
GB9929569D0 (en)	2000-02-09	Therapeutic agents
GB9911802D0 (en)	1999-07-21	Therapeutic combination
GB9911803D0 (en)	1999-07-21	Therapeutic combination
GB9914744D0 (en)	1999-08-25	Therapeutic agents
GB9911804D0 (en)	1999-07-21	Therapeutic combination
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9903119D0 (en)	1999-04-07	Therapeutic agents
GB9914745D0 (en)	1999-08-25	Therapeutic agents
GB9914742D0 (en)	1999-08-25	Therapeutic agents
GB9902881D0 (en)	1999-03-31	Therapeutic agents
GB9914743D0 (en)	1999-08-25	Therapeutic agents

Legal Events

Date	Code	Title	Description
2000-09-20	AT	Applications terminated before publication under section 16(1)